Filing Flows › Comparisons › MRAI vs MGRX
Marpai vs Mangoceuticals: MRAI and MGRX compared
Marpai is the larger company: $4.2M of revenue in its latest quarter (Q2 2026) against $69K for Mangoceuticals (Q2 2026). Marpai is growing faster (-10% against -59% a year earlier).
Where the money goes: MRAI and MGRX
Marpai (MRAI) · Q2 2026
Marpai, Q2 2026: revenue $4.2M (-10% year over year), operating margin -82.4%, net loss $4.6M, operating cash flow −$4.1M. The chart follows the revenue to costs, profit and cash.
Mangoceuticals (MGRX) · Q2 2026
Mangoceuticals, Q2 2026: revenue $69K (-59% year over year), net loss $1.3M, operating cash flow −$261K. The chart follows the revenue to costs, profit and cash.
| Marpai (MRAI) | Mangoceuticals (MGRX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $4.2M | $69K |
| Revenue growth, Y/Y | -10% | -59% |
| Operating margin | -82.4% | n/m |
| Net earnings | −$4.6M | −$1.3M |
| Net margin | -110.0% | — |
| Operating cash flow | −$4.1M | −$261K |
Questions
Which is bigger, Marpai or Mangoceuticals?
Marpai is the larger company: $4.2M of revenue in its latest quarter (Q2 2026) against $69K for Mangoceuticals (Q2 2026).
Is Marpai or Mangoceuticals growing faster?
Marpai is growing faster (-10% against -59% a year earlier).
More: Marpai earnings · how Marpai makes money · Mangoceuticals earnings · how Mangoceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.